Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Half Dose Alteplase for Moderate Pulmonary Embolism
NCT02604238Phase 3Withdrawn
- Sponsor
- Azienda USL 1 di Massa e Carrara
- Start
- Mar 2016
- Primary completion
- Mar 2016
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of tissue-plasminogen activator in pulmonary embolism (PE), sponsored by Azienda USL 1 di Massa e Carrara. Planned start Mar 2016; status: withdrawn.
02
Drugs
tissue-plasminogen activator
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT02604238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02604238.